ISSN 2382-6363
E-ISSN 2382-6371
Journal of Medicines Development Sciences
Editor-in-Chief: Boeynaems Jean Marie
The Journal of Medicines Development Sciences focuses on the discovery and development of new medicinal products. The journal publishes original research articles on medicinal chemistry, experimental pharmacology including pharmacokinetics, preclinical safety, clinical pharmacology, pharmacogenomics, clinical research, pharmacoepidemiology and pharmacoeconomics. The journal also publishes brief reports on new research findings and review articles. Articles encouraging taking the therapy from bench to bedside and creating a broad readership of young researchers, clinicians and scientists are welcome.
The authors are required to pay the Article Processing Charge (APC) for publishing with the journal to cover the cost incurred in processing the manuscripts in order to ensure the contents are freely available and to maintain publishing quality. The manuscript processing includes peer review, copy-editing, typesetting, publishing, content depositing and archiving processes. An invoice of APC will be issued after a paper has been accepted, where authors are advised to pay the APC within one week to avoid delay in publication.
In the event that authors insist to withdraw a submission on unethical and unreasonable grounds, a submission withdrawal fee at 30% of the prevailing Article Processing Charge will be levied on the authors. In general, the editors of Bio-Byword Scientific consider the following *unethical and unreasonable reasons* of withdrawing a submission: